The study revealed that while galectin-4 expression was relatively consistent in different tumor tissues, the expression of membranous MEP1A in mucinous ovarian carcinomas (MOCs) was significantly lower than that in gastrointestinal cancer. This evidence concerns the gene MEP1A and neoplasm.